CDK inhibition
Interviews and expert commentary tagged “CDK inhibition” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Mark A Dickson, ASCO 2026: Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with Advanced Dedifferentiated Liposarcoma
Abemaciclib Brings Marked Increase in Progression Free Survival for Patients with Advanced Dedifferentiated Liposarcoma An interview with: Mark A Dickson MD, Medical Oncologist, Associate Attending Ph
15 June 2026
7:24